Study provides an important advancement of knowledge by showing neural compensation in healthy aging brains

Pathios Ther­a­peu­tics drew in $25 mil­lion for the first close of a Se­ries B raise that should help the UK biotech test its first-in-class sol­id

Eli Lil­ly is ex­pect­ing sup­ply dis­rup­tions for its block­buster weight loss and di­a­betes prod­ucts to con­tin­ue through the end of this year, ex­ec­u­tives told in­vestors.